Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Cyclically Adjusted FCF per Share: ¥0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603229 Zhejiang Ausun Pharmaceutical Co Ltd SHSE:603229
88 GF Score
Price ¥8.29
GF Value ¥9.58
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Zhejiang Ausun Pharmaceutical Co Cyclically Adjusted FCF per Share?

Zhejiang Ausun Pharmaceutical Co SHSE:603229 +1.47% 88 Cyclically Adjusted FCF per Share is ¥0.00 as of Mar. 2026. GuruFocus rates SHSE:603229 with a GF Score™ of 88/100 and a GF Value™ of ¥9.58 (Modestly Undervalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Zhejiang Ausun Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥-0.074. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.00 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-11), Zhejiang Ausun Pharmaceutical Co's current stock price is ¥8.29. Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥0.00. Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Zhejiang Ausun Pharmaceutical Co was 4081.32. The lowest was 949.00. And the median was 1008.00.


Zhejiang Ausun Pharmaceutical Co  (SHSE:603229) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Zhejiang Ausun Pharmaceutical Co was 4081.32. The lowest was 949.00. And the median was 1008.00.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Zhejiang Ausun Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms


Zhejiang Ausun Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Ausun Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Zhejiang Ausun Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.01 0.00

Zhejiang Ausun Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 0.01 0.00 0.00

SHSE:603229 vs VRTX, REGN, RVMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Ausun Pharmaceutical Co Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:603229
88GF Score
Zhejiang Ausun Pharmaceutical Co Ltd SHSE:603229
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Ausun Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Ausun Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.074/116.3033*116.3033
=-0.074

Current CPI (Mar. 2026) = 116.3033.

Zhejiang Ausun Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.005 101.400 0.006
201609 0.086 102.400 0.098
201612 0.046 102.600 0.052
201703 -0.010 103.200 -0.011
201706 0.002 103.100 0.002
201709 -0.027 104.100 -0.030
201712 0.029 104.500 0.032
201803 -0.012 105.300 -0.013
201806 -0.017 104.900 -0.019
201809 -0.013 106.600 -0.014
201812 -0.012 106.500 -0.013
201903 -0.008 107.700 -0.009
201906 0.016 107.700 0.017
201909 0.020 109.800 0.021
201912 0.025 111.200 0.026
202003 -0.023 112.300 -0.024
202006 0.047 110.400 0.050
202009 0.012 111.700 0.012
202012 0.012 111.500 0.013
202103 -0.116 112.662 -0.120
202106 0.109 111.769 0.113
202109 -0.077 112.215 -0.080
202112 -0.075 113.108 -0.077
202203 -0.146 114.335 -0.149
202206 -0.044 114.558 -0.045
202209 0.001 115.339 0.001
202212 0.027 115.116 0.027
202303 -0.024 115.116 -0.024
202306 0.007 114.558 0.007
202309 -0.094 115.339 -0.095
202312 0.189 114.781 0.192
202403 0.007 115.227 0.007
202406 -0.026 114.781 -0.026
202409 0.006 115.785 0.006
202412 0.091 114.893 0.092
202503 -0.038 115.116 -0.038
202506 0.029 114.907 0.029
202509 0.094 115.471 0.095
202512 -0.018 115.832 -0.018
202603 -0.074 116.303 -0.074

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.00 mean?
Zhejiang Ausun Pharmaceutical Co (SHSE:603229) has a Cyclically Adjusted FCF per Share of ¥0.00 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Zhejiang Ausun Pharmaceutical Co and its competitors.
Is Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted FCF per Share too high?
Zhejiang Ausun Pharmaceutical Co's current Cyclically Adjusted FCF per Share is ¥0.00. Overall, Zhejiang Ausun Pharmaceutical Co has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted FCF per Share of ¥0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Zhejiang Ausun Pharmaceutical Co and its competitors. Zhejiang Ausun Pharmaceutical Co's current Cyclically Adjusted FCF per Share is ¥0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Ausun Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Ausun Pharmaceutical Co (SHSE:603229) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥9.58, compared to a current price of ¥8.29 — trading 13.5% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.00. Zhejiang Ausun Pharmaceutical Co's overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Zhejiang Ausun Pharmaceutical Co (SHSE:603229), the current Cyclically Adjusted FCF per Share is ¥0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Ausun Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥8.29 is trading 13.5% below its estimated GF Value™ of ¥9.58. GuruFocus considers Zhejiang Ausun Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:603229:

  • Cyclically Adjusted FCF per Share: ¥0.00
  • GF Value™: ¥9.58 vs. price of ¥8.29 (13.5% below fair value)
  • GF Score™: 88/100 with 8 warning signs

No single metric tells the full story. See the SHSE:603229 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhejiang Ausun Pharmaceutical Co Business Description

Address No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.
88GF Score

Get the complete analysis for SHSE:603229

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.29
Price
¥9.58
GF Value